507 related articles for article (PubMed ID: 29580106)
1. Flagellin as a vaccine adjuvant.
Cui B; Liu X; Fang Y; Zhou P; Zhang Y; Wang Y
Expert Rev Vaccines; 2018 Apr; 17(4):335-349. PubMed ID: 29580106
[TBL] [Abstract][Full Text] [Related]
2. Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.
Gupta SK; Bajwa P; Deb R; Chellappa MM; Dey S
Clin Vaccine Immunol; 2014 Mar; 21(3):261-70. PubMed ID: 24451328
[TBL] [Abstract][Full Text] [Related]
3. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
Yan Y; Yao D; Li X
Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
[TBL] [Abstract][Full Text] [Related]
4. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
[TBL] [Abstract][Full Text] [Related]
5. Immune response of Atlantic salmon to recombinant flagellin.
Hynes NA; Furnes C; Fredriksen BN; Winther T; Bøgwald J; Larsen AN; Dalmo RA
Vaccine; 2011 Oct; 29(44):7678-87. PubMed ID: 21843579
[TBL] [Abstract][Full Text] [Related]
6. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
7. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
[TBL] [Abstract][Full Text] [Related]
8. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.
Kaur A; Kannan D; Mehta SK; Singh S; Salunke DB
Expert Opin Ther Pat; 2018 Nov; 28(11):837-847. PubMed ID: 30280939
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
11. [An update on vaccines. Theory, realities and myths (I)].
Martínez-Mateo P; Bustos-Fonseca MJ; Gil-Díaz MJ
Semergen; 2012 Apr; 38(3):160-6. PubMed ID: 24895720
[TBL] [Abstract][Full Text] [Related]
12. Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.
Monaris D; Sbrogio-Almeida ME; Dib CC; Canhamero TA; Souza GO; Vasconcellos SA; Ferreira LC; Abreu PA
Clin Vaccine Immunol; 2015 Aug; 22(8):965-73. PubMed ID: 26108285
[TBL] [Abstract][Full Text] [Related]
13. Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner.
Hancz D; Szabo A; Molnar T; Varga Z; Hancz A; Gregus A; Hueber AO; Rajnavolgyi E; Koncz G
Immunol Lett; 2018 Jan; 193():42-50. PubMed ID: 29175315
[TBL] [Abstract][Full Text] [Related]
14. The GM-CSF Released by Airway Epithelial Cells Orchestrates the Mucosal Adjuvant Activity of Flagellin.
Vijayan A; Van Maele L; Fougeron D; Cayet D; Sirard JC
J Immunol; 2020 Nov; 205(10):2873-2882. PubMed ID: 33008952
[TBL] [Abstract][Full Text] [Related]
15. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
16. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
Honko AN; Sriranganathan N; Lees CJ; Mizel SB
Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
[TBL] [Abstract][Full Text] [Related]
17. Airway structural cells regulate TLR5-mediated mucosal adjuvant activity.
Van Maele L; Fougeron D; Janot L; Didierlaurent A; Cayet D; Tabareau J; Rumbo M; Corvo-Chamaillard S; Boulenouar S; Jeffs S; Vande Walle L; Lamkanfi M; Lemoine Y; Erard F; Hot D; Hussell T; Ryffel B; Benecke AG; Sirard JC
Mucosal Immunol; 2014 May; 7(3):489-500. PubMed ID: 24064672
[TBL] [Abstract][Full Text] [Related]
18. Flagellin as carrier and adjuvant in cocaine vaccine development.
Lockner JW; Eubanks LM; Choi JL; Lively JM; Schlosburg JE; Collins KC; Globisch D; Rosenfeld-Gunn RJ; Wilson IA; Janda KD
Mol Pharm; 2015 Feb; 12(2):653-62. PubMed ID: 25531528
[TBL] [Abstract][Full Text] [Related]
19. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
Moyle PM
Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-based vaccine adjuvants - discovery and development.
Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
